Expanding Criteria for Resectability of Colorectal Liver Metastases

Oncologist - Tập 13 Số 1 - Trang 51-64 - 2008
Timothy M. Pawlik1, Richard D. Schulick1, Michael A. Choti1
1Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Tóm tắt

Abstract Learning Objectives After completing this course, the reader will be able to: Identify the criteria for hepatic resection of colorectal metastases.Describe strategies for expanding the number of patients who may potentially benefit from hepatic resection.List the factors associated with poor prognosis following hepatic resection. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com Surgical resection is the treatment of choice in patients with colorectal liver metastases, with 5-year survival rates reported in the range of 40%–58%. Over the past 10 years, there has been an impetus to expand the criteria for defining resectability for patients with colorectal metastases. In the past, such features as the number of metastases (three to four), the size of the tumor lesion, and a mandatory 1-cm margin of resection dictated who was “resectable.” More recently, the criteria for resectability have been expanded to include any patient in whom all disease can be removed with a negative margin and who has adequate hepatic volume/reserve. Specifically, instead of resectability being defined by what is removed, decisions concerning resectability now center around what will remain after resection. Under this new paradigm, the number of patients with resectable disease can be expanded by increasing/preserving hepatic reserve (e.g., portal vein embolization, two-stage hepatectomy), combining resection with ablation, and decreasing tumor size (preoperative chemotherapy). The criteria for resectability have also expanded to include patients with extrahepatic disease. Rather than being an absolute contraindication to surgery, patients with both intra- and extrahepatic disease should potentially be considered for resection based on strict selection criteria. The expansion of criteria for resectability of colorectal liver metastases requires a much more nuanced and sophisticated approach to the patient with advanced disease. A therapeutic approach that includes all aspects of multidisciplinary and multimodality care is required to select and treat this complex group of patients.

Từ khóa


Tài liệu tham khảo

Jemal, 2005, Cancer statistics, 2005, CA Cancer J Clin, 55, 10, 10.3322/canjclin.55.1.10

Steele, 1989, Resection of hepatic metastases from colorectal cancer. Biologic perspective, Ann Surg, 210, 127, 10.1097/00000658-198908000-00001

Cady, 1970, Survival of patients after colonic resection for carcinoma with simultaneous liver metastases, Surg Gynecol Obstet, 131, 697

Blumgart, 1982, Resection and embolization in the management of secondary hepatic tumors, World J Surg, 6, 32, 10.1007/BF01656371

Jatzko, 1991, Simultaneous resection of colorectal carcinoma and synchronous liver metastases in a district hospital, Int J Colorectal Dis, 6, 111, 10.1007/BF00300206

Finlay, 1986, Occult hepatic metastases in colorectal carcinoma, Br J Surg, 73, 732, 10.1002/bjs.1800730918

Scheele, 1995, Resection of colorectal liver metastases, World J Surg, 19, 59, 10.1007/BF00316981

Altendorf-Hofmann, 2003, A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma, Surg Oncol Clin N Am, 12, 165, 10.1016/S1055-3207(02)00091-1

Scheele, 1991, Indicators of prognosis after hepatic resection for colorectal secondaries, Surgery, 110, 13

Fong, 1999, Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases, Ann Surg, 230, 309, 10.1097/00000658-199909000-00004

Abdalla, 2004, Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases, Ann Surg, 239, 818, 10.1097/01.sla.0000128305.90650.71

Scheele, 1990, Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history, Br J Surg, 77, 1241, 10.1002/bjs.1800771115

Choti, 2002, Trends in long-term survival following liver resection for hepatic colorectal metastases, Ann Surg, 235, 759, 10.1097/00000658-200206000-00002

Hughes, 1988, Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors, Dis Colon Rectum, 31, 1, 10.1007/BF02552560

Adson, 1984, Resection of hepatic metastases from colorectal cancer, Arch Surg, 119, 647, 10.1001/archsurg.1984.01390180015003

Schlag, 1990, Resection of liver metastases in colorectal cancer—competitive analysis of treatment results in synchronous versus metachronous metastases, Eur J Surg Oncol, 16, 360

Gayowski, 1994, Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors, Surgery, 116, 703

Jenkins, 1997, Hepatic resection for metastatic colorectal cancer, Am Surg, 63, 605

Jamison, 1997, Hepatic resection for metastatic colorectal cancer results in cure for some patients, Arch Surg, 132, 505, 10.1001/archsurg.1997.01430290051008

Jaffe, 1968, Factors influencing survival in patients with untreated hepatic metastases, Surg Gynecol Obstet, 127, 1

Bengmark, 1969, The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy, Cancer, 23, 198, 10.1002/1097-0142(196901)23:1<198::AID-CNCR2820230126>3.0.CO;2-J

de Brauw, 1987, Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases, J Surg Oncol, 34, 81, 10.1002/jso.2930340204

Bengtsson, 1981, Natural history of patients with untreated liver metastases from colorectal cancer, Am J Surg, 141, 586, 10.1016/0002-9610(81)90057-X

Goslin, 1982, Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum, Dis Colon Rectum, 25, 749, 10.1007/BF02553304

1992, Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project, J Clin Oncol, 10, 896, 10.1200/JCO.1992.10.6.896

Saltz, 2000, Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group, N Engl J Med, 343, 905, 10.1056/NEJM200009283431302

de Gramont, 1997, Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study, J Clin Oncol, 15, 808, 10.1200/JCO.1997.15.2.808

Douillard, 2000, Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial, Lancet, 355, 1041, 10.1016/S0140-6736(00)02034-1

Goldberg, 2004, A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer, J Clin Oncol, 22, 23, 10.1200/JCO.2004.09.046

de Gramont, 2000, Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer, J Clin Oncol, 18, 2938, 10.1200/JCO.2000.18.16.2938

Cunningham, 1998, Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer, Lancet, 352, 1413, 10.1016/S0140-6736(98)02309-5

Rougier, 1998, Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer, Lancet, 352, 1407, 10.1016/S0140-6736(98)03085-2

Rothenberg, 2003, Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: Interim results of a phase III trial, J Clin Oncol, 21, 2059, 10.1200/JCO.2003.11.126

Hurwitz, 2004, Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer, N Engl J Med, 350, 2335, 10.1056/NEJMoa032691

Saltz, 2004, Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor, J Clin Oncol, 22, 1201, 10.1200/JCO.2004.10.182

Moertel, 1994, Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group, J Clin Oncol, 12, 21, 10.1200/JCO.1994.12.1.21

Ekberg, 1986, Determinants of survival in liver resection for colorectal secondaries, Br J Surg, 73, 727, 10.1002/bjs.1800730917

Hughes, 1986, Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence, Surgery, 100, 278

Pawlik, 2006, Debunking dogma: Surgery for four or more colorectal liver metastases is justified, J Gastrointest Surg, 10, 240, 10.1016/j.gassur.2005.07.027

Nordlinger, 1996, Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie, Cancer, 77, 1254, 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I

Fortner, 1984, Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection, Ann Surg, 199, 306, 10.1097/00000658-198403000-00010

Doci, 1991, One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants, Br J Surg, 78, 797, 10.1002/bjs.1800780711

Cady, 1998, Surgical margin in hepatic resection for colorectal metastasis: A critical and improvable determinant of outcome, Ann Surg, 227, 566, 10.1097/00000658-199804000-00019

Pawlik, 2005, Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases, Ann Surg, 241, 715, 10.1097/01.sla.0000160703.75808.7d

Fong, 1997, Liver resection for colorectal metastases, J Clin Oncol, 15, 938, 10.1200/JCO.1997.15.3.938

Cady, 1992, Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases, Arch Surg, 127, 561, 10.1001/archsurg.1992.01420050085011

Ferrero, 2007, Postoperative liver dysfunction and future remnant liver: Where is the limit? Results of a prospective study, World J Surg, 31, 1643, 10.1007/s00268-007-9123-2

Abdalla, 2002, Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization, Arch Surg, 137, 675, 10.1001/archsurg.137.6.675

Abdalla, 2004, Total and segmental liver volume variations: Implications for liver surgery, Surgery, 135, 404, 10.1016/j.surg.2003.08.024

Abdalla, 2001, Portal vein embolization: Rationale, technique and future prospects, Br J Surg, 88, 165, 10.1046/j.1365-2168.2001.01658.x

Madoff, 2003, Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: Safety and effectiveness—study in 26 patients, Radiology, 227, 251, 10.1148/radiol.2271012010

Vauthey, 2000, Standardized measurement of the future liver remnant prior to extended liver resection: Methodology and clinical associations, Surgery, 127, 512, 10.1067/msy.2000.105294

Farges, 2003, Portal vein embolization before right hepatectomy: Prospective clinical trial, Ann Surg, 237, 208, 10.1097/01.SLA.0000048447.16651.7B

Uesaka, 1996, Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion, Ann Surg, 223, 77, 10.1097/00000658-199601000-00011

Nagino, 1995, Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma, Surgery, 117, 677, 10.1016/S0039-6060(95)80012-3

Elias, 1995, Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors, J Am Coll Surg, 180, 213

Bismuth, 1996, Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy, Ann Surg, 224, 509, 10.1097/00000658-199610000-00009

Adam, 2000, Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors, Ann Surg, 232, 777, 10.1097/00000658-200012000-00006

Jaeck, 2004, A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases, Ann Surg, 240, 1037, 10.1097/01.sla.0000145965.86383.89

Bolton, 2000, Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma, Ann Surg, 231, 743, 10.1097/00000658-200005000-00015

Elias, 1999, During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma, Br J Surg, 86, 784, 10.1046/j.1365-2168.1999.01154.x

Kianmanesh, 2003, Right portal vein ligation: A new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases, J Am Coll Surg, 197, 164, 10.1016/S1072-7515(03)00334-X

Elias, 2000, Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy, Eur J Surg Oncol, 26, 763, 10.1053/ejso.2000.1000

Yang, 1993, Sonographic and computed tomography characteristics of liver ablation lesions induced by high-intensity focussed ultrasound, Invest Radiol, 28, 796, 10.1097/00004424-199328090-00004

Sibille, 1993, Extracorporeal ablation of liver tissue by high-intensity focused ultrasound, Oncology, 50, 375, 10.1159/000227213

Vogl, 2003, Liver metastases: Neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy, Radiology, 229, 457, 10.1148/radiol.2292021329

Christophi, 2004, Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy, World J Surg, 28, 987, 10.1007/s00268-004-7202-1

Buscombe, 2002, Interventional nuclear medicine in hepatocellular carcinoma and other tumours, Nucl Med Commun, 23, 837, 10.1097/00006231-200209000-00005

Simon, 2006, Intraoperative triple antenna hepatic microwave ablation, AJR Am J Roentgenol, 187, W333, 10.2214/AJR.05.0804

Dong, 2003, Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: Results in 234 patients, AJR Am J Roentgenol, 180, 1547, 10.2214/ajr.180.6.1801547

Rhim, 1999, Radiofrequency thermal ablation of liver tumors, J Clin Ultrasound, 27, 221, 10.1002/(SICI)1097-0096(199906)27:5<221::AID-JCU1>3.0.CO;2-T

McGahan, 1992, Hepatic ablation with use of radio-frequency electrocautery in the animal model, J Vasc Interv Radiol, 3, 291, 10.1016/S1051-0443(92)72028-4

Curley, 2004, Surgical treatment of colorectal cancer metastasis, Cancer Metastasis Rev, 23, 165, 10.1023/A:1025875332255

Curley, 1997, Laparoscopically guided bipolar radiofrequency ablation of areas of porcine liver, Surg Endosc, 11, 729, 10.1007/s004649900437

Pawlik, 2003, Combined resection and radiofrequency ablation for advanced hepatic malignancies: Results in 172 patients, Ann Surg Oncol, 10, 1059, 10.1245/ASO.2003.03.026

Curley, 1999, Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients, Ann Surg, 230, 1, 10.1097/00000658-199907000-00001

Wood, 2000, Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications, Ann Surg Oncol, 7, 593, 10.1007/BF02725339

Bilchik, 2001, Radiofrequency ablation of unresectable hepatic malignancies: Lessons learned, The Oncologist, 6, 24, 10.1634/theoncologist.6-1-24

Machi, 2001, Ultrasound-guided radiofrequency thermal ablation of liver tumors: Percutaneous, laparoscopic, and open surgical approaches, J Gastrointest Surg, 5, 477, 10.1016/S1091-255X(01)80085-8

Aloia, 2006, Solitary colorectal liver metastasis: Resection determines outcome, Arch Surg, 141, 460, 10.1001/archsurg.141.5.460

van Duijnhoven, 2006, Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases, Ann Surg Oncol, 13, 651, 10.1245/ASO.2006.08.014

de Baere, 2000, Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year, AJR Am J Roentgenol, 175, 1619, 10.2214/ajr.175.6.1751619

Solbiati, 2001, Radiofrequency thermal ablation of hepatic metastases, Eur J Ultrasound, 13, 149, 10.1016/S0929-8266(01)00127-6

Gillams, 2001, Thermal ablation of liver metastases, Abdom Imaging, 26, 361, 10.1007/s002610000196

Adam, 2004, Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival, Ann Surg, 240, 644, 10.1097/01.sla.0000141198.92114.f6

Adam, 2001, Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal, Ann Surg Oncol, 8, 347, 10.1007/s10434-001-0347-3

Rivoire, 2002, Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma, Cancer, 95, 2283, 10.1002/cncr.10973

Fowler, 1992, Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma, J Surg Oncol, 51, 122, 10.1002/jso.2930510212

Wein, 2001, Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid, Ann Oncol, 12, 1721, 10.1023/A:1013521430755

Rubbia-Brandt, 2004, Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer, Ann Oncol, 15, 460, 10.1093/annonc/mdh095

Fernandez, 2005, Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases, J Am Coll Surg, 200, 845, 10.1016/j.jamcollsurg.2005.01.024

Pawlik, 2007, Preoperative chemotherapy for colorectal liver metastases: Impact on hepatic histology and postoperative outcome, J Gastrointest Surg, 11, 860, 10.1007/s11605-007-0149-4

Vauthey, 2006, Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases, J Clin Oncol, 24, 2065, 10.1200/JCO.2005.05.3074

Benoist, 2006, Complete response of colorectal liver metastases after chemotherapy: Does it mean cure?, J Clin Oncol, 24, 3939, 10.1200/JCO.2006.05.8727

Nagakura, 2001, Simultaneous detection of colorectal carcinoma liver and lung metastases does not warrant resection, J Am Coll Surg, 193, 153, 10.1016/S1072-7515(01)00970-X

Elias, 2004, Results of R0 resection for colorectal liver metastases associated with extrahepatic disease, Ann Surg Oncol, 11, 274, 10.1245/ASO.2004.03.085

Ferrero, 2004, Extensive resections for colorectal liver metastases, J Hepatobiliary Pancreat Surg, 11, 92, 10.1007/s00534-002-0792-9

Elias, 2003, Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases, Br J Surg, 90, 567, 10.1002/bjs.4071

Inoue, 2000, Surgery for pulmonary metastases from colorectal carcinoma, Ann Thorac Surg, 70, 380, 10.1016/S0003-4975(00)01417-X

Inoue, 2004, Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma, Ann Thorac Surg, 78, 238, 10.1016/j.athoracsur.2004.02.017

Sakamoto, 2001, Pulmonary resection for metastases from colorectal cancer, Chest, 119, 1069, 10.1378/chest.119.4.1069

Murata, 1998, Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma, Cancer, 83, 1086, 10.1002/(SICI)1097-0142(19980915)83:6<1086::AID-CNCR6>3.0.CO;2-6

Kobayashi, 1999, Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer, J Thorac Cardiovasc Surg, 118, 1090, 10.1016/S0022-5223(99)70106-6

Headrick, 2001, Surgical treatment of hepatic and pulmonary metastases from colon cancer, Ann Thorac Surg, 71, 975, 10.1016/S0003-4975(00)02522-4

Shah, 2006, Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma, J Am Coll Surg, 202, 468, 10.1016/j.jamcollsurg.2005.11.008

Mineo, 2003, Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma, J Am Coll Surg, 197, 386, 10.1016/S1072-7515(03)00387-9

Iwatsuki, 1999, Hepatic resection for metastatic colorectal adenocarcinoma: A proposal of a prognostic scoring system, J Am Coll Surg, 189, 291, 10.1016/S1072-7515(99)00089-7

Nakamura, 1999, Resection of hepatic metastases of colorectal carcinoma: 20 years' experience, J Hepatobiliary Pancreat Surg, 6, 16, 10.1007/s005340050079

Jaeck, 2003, The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies, Ann Surg Oncol, 10, 1007, 10.1245/ASO.2003.09.903

Jaeck, 2002, Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: A prospective study, Ann Surg Oncol, 9, 430, 10.1007/BF02557264

da Silva, 2006, Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer, J Am Coll Surg, 203, 878, 10.1016/j.jamcollsurg.2006.08.024

Glehen, 2004, Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study, J Clin Oncol, 22, 3284, 10.1200/JCO.2004.10.012

McAfee, 1992, Colorectal lung metastases: Results of surgical excision, Ann Thorac Surg, 53, 780, 10.1016/0003-4975(92)91435-C

Mansel, 1986, Pulmonary resection of metastatic colorectal adenocarcinoma. A ten year experience, Chest, 89, 109, 10.1378/chest.89.1.109

Joyce, 2006, Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases, Arch Surg, 141, 1220, 10.1001/archsurg.141.12.1220

Giacchetti, 2000, Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer, J Clin Oncol, 18, 136, 10.1200/JCO.2000.18.1.136

Kohne, 2005, Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986, J Clin Oncol, 23, 4856, 10.1200/JCO.2005.05.546

Tournigand, 2004, FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study, J Clin Oncol, 22, 229, 10.1200/JCO.2004.05.113

Thông tin
Thông tin xuất bản

Oncologist

Tập 13 Số 1

51-64

Thông tin tác giả